RiceBran Technologies (RIBT)

[wow_happens28]

Stabilized Rice Bran treatment for Alzheimer’s

NW a fellow shareholder saw your post and sent me the below>>>>>

One of my good friends xxx xxxxxxxx who has Alzheimer's is living proof this story is spot on. I introduced xxx to Ricebran over ten years after speaking with Patty McPeak about Ben's condition. He was diagnosed with stage 4 and he has been in reversal over the last years. Ben takes 2-4 super boosts of RiceBran SRB daily. You would never know he has Alzheimer's disease. Thought you enjoy knowing this about stabilized rice bran.

Your post NW>>>

Stabilized Rice Bran treatment for Alzheimer’s

https://www.prnewswire.com/news-releases/nurishme-a-leader-in-highly-advanced-rejuvenation-products-announces-the-release-of-the-new-and-enhanced-cogninurish-pro-based-on-discoveries-from-the-landmark-alzheimers-study-and-other-clinical-trials-for-even-greater-effi-300971941.html

This original, proprietary formula contains the key ingredients used in Lewis's groundbreaking study: aloe vera inner leaf powder (BiAloe) and stabilized rice bran. "BiAloe's polysaccharides are more concentrated and more bioavailable than any other aloe vera available. The stabilized rice bran, which has an astounding number of essential nutrients and hundreds of other phytochemicals, creates a broad-spectrum approach to providing the body the raw materials it needs to enable the bioengineering of life.

Participants were given one teaspoon, four times a day, of a dietary supplement with multiple natural ingredients, including a very special form of aloe vera and stabilized rice bran. "Overall, our results showed statistically and clinically significant improvements in cognitive functioning and statistically significant improvements in immune functioning for a disease that otherwise has no efficacious medical treatment," Lewis states. "Many participants had a renewed ability to recall people, places, events and situations, which was remarkable given their disease severity and from what the caregivers reported to us." Perhaps the most extraordinary finding from the study was the change in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), which is the preeminently used and published measure to asses cognitive functioning in dementia studies. A 4-point improvement is considered clinically significant. In this landmark study, the improvement in the ADAS-Cog was greater than 4 points at 9- and 12-months follow-up, and the improvement was even greater in participants who were not taking one of the five FDA-approved drugs for dementia.

CogniNurish Pro is scheduled to be available to consumers in Q1 of 2020.